Taro Company Profile
✉ Email this page to a colleague
What is the competitive landscape for TARO
TARO has one hundred and twenty-eight approved drugs.
There are two US patents protecting TARO drugs. There is one tentative approval on TARO drugs.
There are nine patent family members on TARO drugs in six countries and two hundred and seven supplementary protection certificates in seventeen countries.
Summary for Taro
| International Patents: | 9 |
| US Patents: | 2 |
| Tradenames: | 90 |
| Ingredients: | 79 |
| NDAs: | 128 |
| Patent Litigation for Taro: | See patent lawsuits for Taro |
| PTAB Cases with Taro as petitioner: | See PTAB cases with Taro as petitioner |
Drugs and US Patents for Taro
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Taro | MINOXIDIL (FOR MEN) | minoxidil | AEROSOL, FOAM;TOPICAL | 209074-001 | Dec 31, 2018 | OTC | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Taro | PERAMPANEL | perampanel | TABLET;ORAL | 209538-004 | Nov 25, 2025 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Taro | HYDROCORTISONE AND ACETIC ACID | acetic acid, glacial; hydrocortisone | SOLUTION/DROPS;OTIC | 088759-001 | Mar 4, 1985 | AT | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Paragraph IV (Patent) Challenges for TARO drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Topical Spray | 0.25% | ➤ Subscribe | 2013-12-18 |
| ➤ Subscribe | Topical Lotion | 0.5% | ➤ Subscribe | 2011-03-16 |
International Patents for Taro Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| China | 103087095 | ⤷ Start Trial |
| Japan | 5474347 | ⤷ Start Trial |
| Canada | 2612578 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Taro Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1713823 | 1490064-1 | Sweden | ⤷ Start Trial | PRODUCT NAME: SIMEPREVIR, OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, INCLUDING SIMEPREVIR SODIUM; REG. NO/DATE: EU/1/14/924 20140516 |
| 2465580 | SPC/GB21/030 | United Kingdom | ⤷ Start Trial | PRODUCT NAME: CABOTEGRAVIR OR A PHARMACEUTICALLY ACCEPTABLE SALT OR SOLVATE THEREOF, INCLUDING CABOTEGRAVIR SODIUM.; REGISTERED: UK EU/1/20/1481 (NI) 20201221; UK PLGB 35728/0055-57 20201221 |
| 0463756 | C990005 | Netherlands | ⤷ Start Trial | PRODUCT NAME: SILDENAFIL, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AAN- VAARDBAAR ZOUT, IN HET BIJZONDER SILDENAFIL CITRAAT; NATL REGISTRATION NO/DATE: EU/1/98/077/001-012 19980914; FIRST REGISTRATION: CH 54642 19980622 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
